Expression of HER2 and COX-2 in non-small cell lung cancer

Yang YANG,Yi MENG,Xiang-shan FAN,Xiao-ping QIAN,Bao-rui LIU,Li-feng WANG
DOI: https://doi.org/10.11877/j.issn.1672-1535.2015.13.05.16
2015-01-01
Abstract:Objective To investigate the expression of HER2 and COX-2 in non-small cell lung cancer (NSCLC) and the association with patients' clinical characteristics. Method The protein expression of HER2 and COX-2 were detected in 72 NSCLC patients by immunohistochemistry with streptavidin-peroxidase (SP) methods. Result (1) The positive expression rate of HER2 and COX-2 were 55.6% and 65.3%, respectively. (2) The expression of HER2 was significantly correlated with histological type, differentiation, size of mass, lymph node metastasis and clinical stage (P<0.05), while it was not related with patients' sex, age, tumor site and smoking status (P>0.05). (3) COX-2 ex-pression was related to patients' age, histological type, mass size, lymph node metastasis and clinical stage (P<0.05), but no significant correlation was found between COX-2 expression and patients ’sex, smoking status, tumor site and differentiation (P>0.05). (4) There was statistically positive correlation between expression of HER2 and COX-2. Conclusion Detection of HER2 and COX-2 can be used as indicators for prognosis in NSCLC.
What problem does this paper attempt to address?